Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Cross Country Healthcare's accounts receivables for the quarter that ended in Mar. 2026 was $177 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Cross Country Healthcare's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 66.87.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Cross Country Healthcare's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was $3.19.
Cross Country Healthcare Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Cross Country Healthcare's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Cross Country Healthcare's accounts receivable are only considered to be worth 75% of book value:
Cross Country Healthcare's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Cross Country Healthcare Accounts Receivable Related Terms
Cross Country Healthcare Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cross Country Healthcare Accounts Receivable Chart
Cross Country Healthcare (CCRN) has a Accounts Receivable of $177 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Cross Country Healthcare and its competitors.
Is Cross Country Healthcare's Accounts Receivable too high?
Cross Country Healthcare's current Accounts Receivable is $177 Mil. Overall, Cross Country Healthcare has a GF Score™ of 45/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cross Country Healthcare's Accounts Receivable compare to SRTA and CYH?
Cross Country Healthcare's Accounts Receivable of $177 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Cross Country Healthcare and its competitors. Cross Country Healthcare's current Accounts Receivable is $177 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cross Country Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cross Country Healthcare (CCRN) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.44, compared to a current price of $13.25 — trading 26.9% above its estimated fair value. The current Accounts Receivable is $177 Mil. Cross Country Healthcare's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Cross Country Healthcare (CCRN), the current Accounts Receivable is $177 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cross Country Healthcare (CCRN) Overvalued in 2026?
Based on GuruFocus' analysis, Cross Country Healthcare stock appears to be overvalued.
The current stock price of $13.25 is trading 26.9% above its estimated GF Value™ of $10.44.
GuruFocus considers Cross Country Healthcare to be Modestly Overvalued.
Key valuation signals for CCRN:
Accounts Receivable: $177 Mil
GF Value™: $10.44 vs. price of $13.25 (26.9% above fair value)
No single metric tells the full story. See the CCRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
45GF Score
Get the complete analysis for CCRN
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCRN has been successfully added to your 
